Rasha Elsabagh | Veterinary Science and Veterinary Medicine | Research Excellence Award

Published on by Forensic Scientist

Dr. Rasha Elsabagh | Veterinary Science and Veterinary Medicine | Research Excellence Award

Animal Health Research Institute (AHRI) | Egypt

Dr. Rasha Elsabagh is a distinguished cancer immunology and stem cell researcher recognized for her extensive expertise in cancer stem cells, immunotherapy, cell-mediated immunity, and plasmonic photothermal therapy. Her work integrates immuno-oncology, stem cell biology, and bio-nanotechnology, emphasizing innovative therapeutic strategies that target tumor-infiltrating immune cells and malignant stem cell populations. Dr. Rasha Elsabagh has made significant contributions to the field through high-impact publications in journals such as Veterinary Oncology, Stem Cell Research & Therapy, Advances in Animal and Veterinary Sciences, and proceedings of the German Stem Cell Network (GSCN), highlighting her pioneering studies on Gold Nano-Rod–mediated plasmonic photothermal therapy in feline mammary carcinoma, quantitative flow cytometry assessment of feline circulatory breast cancer stem cells, and characterization of short cell-cycle duration as a defining feature of human epidermal stem cells. Her research encompasses nano-enabled cancer therapeutics, hematopoietic stem cell differentiation, tumor microenvironment modulation, and RNA-based nanoparticle delivery systems for myeloid cell reprogramming, reflecting a strong focus on translational and precision approaches to cancer treatment. Through international collaborations in Europe and the United States, she has advanced stem cell imaging, immunophenotyping, and multimodal therapeutic evaluation techniques. Dr. Rasha Elsabagh’s contributions have been recognized through competitive fellowships and awards, including a prestigious postdoctoral fellowship from France (IFE–STDF), a USAID-funded research training scholarship, and the GSCN travel award. By presenting her findings at leading international conferences and driving interdisciplinary research initiatives, she continues to advance the frontiers of immunotherapy innovation, stem cell science, and translational cancer research, establishing herself as a prominent leader in her field.

Profile: ORCID

Featured Publications

  • Elsabagh, R. H., Farghali, H. A., Emam, I. A., Abdelrahman, H., Ragab, E., Nada, A. A., & Selim, S. A. (2025). Gold nano-rod (AuNR)-mediated plasmonic photothermal therapy in feline mammary carcinoma: Assessing metastatic and nonmetastatic outcomes. Veterinary Oncology.

  • Xiao, T., Eze, U. C., Charruyer-Reinwald, A., Weisenberger, T., Khalifa, A., Abegaze, B., Schwab, G. K., Elsabagh, R. H., Parenteau, T. R., & Kochanowski, K. et al. (2024). Short cell cycle duration is a phenotype of human epidermal stem cells. Stem Cell Research and Therapy.

  • Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H., Ragab, E., Nada, A. A., & Selim, S. A. (2022). Prevention of in situ recurrence and distant metastasis in feline mammary carcinoma treated with plasmonic photothermal therapy. Research Square.

  • Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Ragab, E., Nada, A. A., & Selim, S. A. (2021). Quantitative flow cytometry assessment of feline circulatory breast cancer stem cells. Advances in Animal and Veterinary Sciences, 9(12), 2201–2215.

Ibrahima Barry | Veterinary Science | Best Researcher Award

Published on by Forensic Scientist

Ibrahima Barry | Veterinary Science | Best Researcher Award

Student in Vaccine Production and Quality Control Program  | Pan African University Life and Earth Sciences Institute (including Health & Agriculture) | Guinea 

Boubacar Barry is a dedicated graduate in Vaccine Production and Quality Control from PAULESI at the University of Ibadan, Nigeria. With a strong background in veterinary vaccine research, he focuses on combating livestock diseases, notably Peste des Petits Ruminants (PPR). His research emphasizes vaccine quality and genetic stability, contributing to Africa’s disease eradication goals.

Profile

Orcid

Strengths for the Award

  • Relevant Expertise in Vaccine Quality Control: Boubacar Barry has focused his research on vaccine production and quality control, specifically targeting the Peste des Petits Ruminants (PPR) virus. His work aligns with critical global efforts toward disease control and eradication.
  • Significant Contributions to Veterinary Sciences: His recent publication on the genetic stability of PPR vaccines produced across Africa is notable. This research has potential policy implications for livestock health management, contributing directly to Africa’s public health initiatives.
  • Collaboration with Renowned Institutions: Through partnerships with institutions like AU-PANVAC and PAULESI, Barry has gained valuable experience and exposure, enriching his research and expanding his professional network.
  • Hands-On Experience in Africa’s Vaccine Landscape: His internship at AU-PANVAC provided practical skills in vaccine quality control, an important asset for his research credibility.

Education 📘

Boubacar holds a Master’s degree in Vaccine Production and Quality Control from the Pan African University Life and Earth Sciences Institute (PAULESI) in Nigeria. His studies focused on the Peste des Petits Ruminants virus, equipping him with essential expertise in vaccine development and quality assurance.

Experience 💼

Boubacar gained practical experience through an internship at AU-PANVAC in Ethiopia, where he worked on vaccine quality control and collaborated with leading scientists in vaccine production. His experience is enriched by his contributions to research and development projects at PAULESI and interactions with professionals across Africa.

Research Interests 🔬

Boubacar’s primary research focus is on the development and quality control of vaccines, especially for PPR in livestock. His work involves studying the genetic stability and molecular evolution of vaccines, aiming to support Africa’s public health and economic resilience against livestock diseases.

Awards & Recognition 🏆

Boubacar’s significant contributions to veterinary vaccine research have garnered nominations for prestigious awards. His work in improving vaccine stability and control aligns with the global agenda to eradicate animal diseases, enhancing his profile as a dedicated researcher in the field.

Publications 📑

  • Partial Sequence Analysis of Commercial Peste des Petits Ruminants Vaccines Produced in Africa (2023) published in Veterinary Sciences MDPI Link to Publication

Conclusion 🌍

Boubacar Barry is a promising scientist dedicated to advancing vaccine research and animal health in Africa. Through collaborations and impactful research, he continues to contribute toward global disease control efforts, reflecting his commitment to public health and scientific progress in veterinary sciences.